UNIQUE BILLING CODE FOR OMIDRIA: C9447
OMIDRIA
™
(phenylephrine and ketorolac injection) 1% / 0.3%
IS REIMBURSED BY CMS
Pass-through status provides payment for OMIDRIA separate from the bundled
APC payment for the surgical procedure.
Payment rates for non-Medicare Part B patients may vary
– Medicare Part C (Medicare Advantage) and other third-party payers may follow the same payment
process as CMS, but are not obligated to do so
INDICATIONS AND USAGE
OMIDRIA is added to ophthalmic irrigation solution used during cataract surgery or intraocular lens
replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing
postoperative ocular pain.
IMPORTANT SAFETY INFORMATION
Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported
ocular adverse reactions at 2-24% are eye irritation, posterior capsule opacifi cation, increased intraocular
pressure, and anterior chamber infl ammation. OMIDRIA must be added to irrigation solution prior to use.
Use of OMIDRIA in children has not been established.
Please see the Full Prescribing Information for
OMIDRIA at www.omidria.com/prescribinginformation.
Omeros
®
and the Omeros logo
®
are registered trademarks, and Omidria
™
and the Omidria logo
™
are trademarks, of Omeros Corporation. © Omeros Corporation 2015, all rights reserved. 2015-072
Visit Booth 417 to learn more
Information contained herein is provided as a reference for obtaining appropriate
and accurate reimbursement for the use of OMIDRIA in eligible patients.
Omeros Corporation does not guarantee that the use of the recommended codes
will result in reimbursement.
